Skip to main content
SpringerLink
Log in

Enhanced platelet activation following coronary stent implantation in patients on hemodialysis

  • Original Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Hemodialysis (“HD”) has been suggested as a risk factor for stent thrombosis. However, platelet function in HD patients after coronary stent implantation remains unclear. The aim of this study was to evaluate platelet function following coronary stent implantation in HD patients. A total of 10 HD and 31 non-HD patients who underwent a first coronary stent implantation were studied. All patients received 100 or 200 mg of asprin and thienopiridine (either ticlopidine 200 mg or clopidogel 75 mg) daily. Platelet function was assessed 2–6 weeks (21 ± 8 days) after stent implantation by: (1) platelet maximal aggregation, using light transmittance aggregometry; (2) platelet aggregation threshold index, which was defined as putative concentration of agonist giving 50% maximum aggregation using whole-blood aggregometry; and (3) platelet activation markers (PAC-1 and CD62p), using whole blood flow cytometry. There were no differences between the two groups in baseline and procedure characteristics, except for a greater prevalence of hypertension and calcification in the HD group. Early stent thrombosis and bleeding did not occur in either group. Although no differences in platelet maximal aggregation or whole-blood aggregation were observed, expression of PAC-1 (39.6 ± 9.1 vs 24.2 ± 13.2%) and CD62p (10.4 ± 5.5 vs 5.4 ± 2.3%) were significantly increased in the HD group compared with the non-HD group. HD patients exhibited enhanced platelet activation after coronary stent implantation, but suppression of platelet aggregation was achieved by the current dual antiplatelet therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542–8.

    Article  CAS  PubMed  Google Scholar 

  2. Rubenstein MH, Harrell LC, Sheynberg BV, Schunkert H, Bazari H, Palacios IF. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation. 2000;102:2966–72.

    CAS  PubMed  Google Scholar 

  3. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799–805.

    Article  CAS  PubMed  Google Scholar 

  4. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999;10:1606–15.

    CAS  PubMed  Google Scholar 

  5. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–30.

    Article  CAS  PubMed  Google Scholar 

  6. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol. 2007;49:1505–16.

    Article  CAS  PubMed  Google Scholar 

  7. Cuisset T, Frere C, Quilici J, Barbou F, Morange PE, Hovasse T, et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost. 2006;4:542–9.

    Article  CAS  PubMed  Google Scholar 

  8. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, et al. Platelet reactivity in patients and recurrent events post-stenting: results of the prepare post-stenting study. J Am Coll Cardiol. 2005;46:1820–6.

    Article  CAS  PubMed  Google Scholar 

  9. Ozeki Y, Sudo T, Toga K, Nagamura Y, Ito H, Ogawa T, et al. Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method. Thromb Res. 2001;101:65–72.

    Article  CAS  PubMed  Google Scholar 

  10. Casserly LF, Dember LM. Thrombosis in end-stage renal disease. Semin Dial. 2003;16:245–56.

    Article  PubMed  Google Scholar 

  11. Di Minno G, Martinez J, McKean ML, De La Rosa J, Burke JF, Murphy S. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med. 1985;79:552–9.

    Article  CAS  PubMed  Google Scholar 

  12. Di Minno G, Cerbone A, Usberti M, Cianciaruso B, Cortese A, Farace MJ, et al. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. J Lab Clin Med. 1986;108:246–52.

    CAS  PubMed  Google Scholar 

  13. Mezzano D, Tagle R, Panes O, Perez M, Downey P, Munoz B, et al. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Thromb Haemost. 1996;76:312–21.

    CAS  PubMed  Google Scholar 

  14. Burgstahler C, Geisler T, Lindemann S, Brodoefel H, Reimann A, Heuschmid M, et al. Elevated coronary calcium scores are associated with higher residual platelet aggregation after clopidogrel treatment in patients with stable angina pectoris. Int J Cardiol. 2009;135:132–5.

    Article  PubMed  Google Scholar 

  15. Cases A, Reverter JC, Escolar G, Sanz C, Lopez-Pedret J, Revert L, et al. Platelet activation on hemodialysis: influence of dialysis membranes. Kidney Int Suppl. 1993;41:S217–20.

    CAS  PubMed  Google Scholar 

  16. Deguchi N, Ohigashi T, Tazaki H, Handa M, Ikeda Y. Haemodialysis and platelet activation. Nephrol Dial Transplant. 1991;6(Suppl 2):40–2.

    PubMed  Google Scholar 

  17. Reverter JC, Escolar G, Sanz C, Cases A, Villamor N, Nieuwenhuis HK, et al. Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flow cytometric and ultrastructural techniques. J Lab Clin Med. 1994;124:79–85.

    CAS  PubMed  Google Scholar 

  18. Kawabata K, Nagake Y, Shikata K, Fukuda S, Nakazono H, Takahashi M, et al. Soluble p-selectin is released from activated platelets in vivo during hemodialysis. Nephron. 1998;78:148–55.

    Article  CAS  PubMed  Google Scholar 

  19. Sirolli V, Strizzi L, Di Stante S, Robuffo I, Procopio A, Bonomini M. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. Thromb Haemost. 2001;86:834–9.

    CAS  PubMed  Google Scholar 

  20. Bonomini M, Sirolli V, Settefrati N, Stuard S, Tropea F, Di Liberato L, et al. Surface antigen expression and platelet neutrophil interactions in haemodialysis. Blood Purif. 1999;17:107–17.

    Article  CAS  PubMed  Google Scholar 

  21. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482–94.

    Article  CAS  PubMed  Google Scholar 

  22. Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, et al. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy. J Am Coll Cardiol. 2000;36:699–705.

    Article  CAS  PubMed  Google Scholar 

  23. Jin RC, Voetsch B, Loscalzo J. Endogenous mechanisms of inhibition of platelet function. Microcirculation. 2005;12:247–58.

    Article  CAS  PubMed  Google Scholar 

  24. Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther. 1999;289:735–41.

    CAS  PubMed  Google Scholar 

  25. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (cox)-2: the human pharmacology of a selective inhibitor of cox-2. Proc Natl Acad Sci USA. 1999;96:272–7.

    Article  CAS  PubMed  Google Scholar 

  26. Moncada S. Adventures in vascular biology: a tale of two mediators. Philos Trans R Soc Lond B Biol Sci. 2006;361:735–59.

    Article  CAS  PubMed  Google Scholar 

  27. Annuk M, Lind L, Linde T, Fellstrom B. Impaired endothelium-dependent vasodilatation in renal failure in humans. Nephrol Dial Transplant. 2001;16:302–6.

    Article  CAS  PubMed  Google Scholar 

  28. Gurbel PA, Bliden KP, Hiatt BL, O’ Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation. 2003;107:2908–13.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Internal Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, Japan

    Qiang Fu, Shuichi Ishikawa, Naoyuki Yokoyama, Ken Kozuma, Kaoru Takada, Aki Muraki & Takaaki Isshiki

Authors
  1. Qiang Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuichi Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naoyuki Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ken Kozuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kaoru Takada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aki Muraki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takaaki Isshiki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takaaki Isshiki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fu, Q., Ishikawa, S., Yokoyama, N. et al. Enhanced platelet activation following coronary stent implantation in patients on hemodialysis. Cardiovasc Interv and Ther 25, 72–77 (2010). https://doi.org/10.1007/s12928-010-0013-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-010-0013-4

Keywords

Search

Navigation